Transcriptional Dynamics of NRF2 Overexpression and KEAP1-NRF2 Inhibitors in Human Cell Line and Primary Lung Cells
Oxidative stress in the human lung is caused by both internal (e.g., inflammation) and external stressors (smoking, pollution, and infection) to drive pathology in a number of lung diseases. Cellular damage caused by oxidative damage is reversed by several pathways, one of which is the antioxidant r...
| Published in: | Antioxidants |
|---|---|
| Main Authors: | Corinne Hamblet, Karin Björhall, Susann Busch, Ulf Gehrmann, Lisa Öberg, Rebekka Kubisch-Dohmen, Sonja Haas, Manish K. Aneja, Johannes Geiger, Carsten Rudolph, Ellinor Hornberg |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-07-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/13/8/924 |
Similar Items
Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA
by: Eva Schrom, et al.
Published: (2017-06-01)
by: Eva Schrom, et al.
Published: (2017-06-01)
KEAP1/NRF2 as a druggable target
by: Dinkova-Kostova Albena T.
Published: (2023-01-01)
by: Dinkova-Kostova Albena T.
Published: (2023-01-01)
CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis
by: Yanbo Wang, et al.
Published: (2021-05-01)
by: Yanbo Wang, et al.
Published: (2021-05-01)
The KEAP1-NRF2 pathway: Targets for therapy and role in cancer
by: Simone Adinolfi, et al.
Published: (2023-07-01)
by: Simone Adinolfi, et al.
Published: (2023-07-01)
Potential Benefits of Nrf2/Keap1 Targeting in Pancreatic Islet Cell Transplantation
by: Alberto Jarrin Lopez, et al.
Published: (2020-04-01)
by: Alberto Jarrin Lopez, et al.
Published: (2020-04-01)
Genetic hyperactivation of Nrf2 causes larval lethality in Keap1a and Keap1b-double-knockout zebrafish
by: Lixuan Bian, et al.
Published: (2023-06-01)
by: Lixuan Bian, et al.
Published: (2023-06-01)
Circular mRNAs: More stable RNAs lead to more persistent protein expression
by: Jiayu Zhang, et al.
Published: (2022-12-01)
by: Jiayu Zhang, et al.
Published: (2022-12-01)
Evaluation of Nrf2/Keap1 Pathway in Patients with Migraine
by: Fatih Koçtürk, et al.
Published: (2025-09-01)
by: Fatih Koçtürk, et al.
Published: (2025-09-01)
Modulation of NRF2/KEAP1 Signaling in Preeclampsia
by: Giovanni Tossetta, et al.
Published: (2023-06-01)
by: Giovanni Tossetta, et al.
Published: (2023-06-01)
The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
by: Carlie Priddy, et al.
Published: (2021-12-01)
by: Carlie Priddy, et al.
Published: (2021-12-01)
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
by: Emilia Kansanen, et al.
Published: (2013-01-01)
by: Emilia Kansanen, et al.
Published: (2013-01-01)
The KEAP1/NRF2 Signaling Pathway in Keratinization
by: Yosuke Ishitsuka, et al.
Published: (2020-08-01)
by: Yosuke Ishitsuka, et al.
Published: (2020-08-01)
Regulation of Cell Proliferation and Nrf2-Mediated Antioxidant Defense: Conservation of Keap1 Cysteines and Nrf2 Binding Site in the Context of the Evolution of KLHL Family
by: Gregory A. Shilovsky, et al.
Published: (2023-04-01)
by: Gregory A. Shilovsky, et al.
Published: (2023-04-01)
KEAP1–NRF2 system regulates age‐related spermatogenesis dysfunction
by: Sohei Kuribayashi, et al.
Published: (2024-01-01)
by: Sohei Kuribayashi, et al.
Published: (2024-01-01)
Oxidative Stress-Induced Misfolding and Inclusion Formation of Nrf2 and Keap1
by: Vy Ngo, et al.
Published: (2022-01-01)
by: Vy Ngo, et al.
Published: (2022-01-01)
Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer
by: Giovanni Tossetta, et al.
Published: (2023-07-01)
by: Giovanni Tossetta, et al.
Published: (2023-07-01)
Glutathione Induces Keap1 S-Glutathionylation and Mitigates Oscillating Glucose-Induced β-Cell Dysfunction by Activating Nrf2
by: Xiufang Chen, et al.
Published: (2024-03-01)
by: Xiufang Chen, et al.
Published: (2024-03-01)
The KEAP1-NRF2 System in Healthy Aging and Longevity
by: Daisuke Matsumaru, et al.
Published: (2021-11-01)
by: Daisuke Matsumaru, et al.
Published: (2021-11-01)
Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance
by: Liam Baird, et al.
Published: (2023-11-01)
by: Liam Baird, et al.
Published: (2023-11-01)
Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer
by: Feilong Chen, et al.
Published: (2024-04-01)
by: Feilong Chen, et al.
Published: (2024-04-01)
The role of the KEAP1-NRF2 signaling pathway in form deprivation myopia guinea pigs
by: Zhiming Gu, et al.
Published: (2024-11-01)
by: Zhiming Gu, et al.
Published: (2024-11-01)
Long noncoding RNA DDX11-AS1 represses sorafenib-induced ferroptosis in hepatocellular carcinoma cells via Nrf2-Keap1 pathway
by: Liang Wang, et al.
Published: (2024-10-01)
by: Liang Wang, et al.
Published: (2024-10-01)
Cymbopogon citratus Essential Oil Protects Tubular Renal Cells against Ischemia/Reoxygenation Injury - Involvement Nrf2/Keap1 Pathway
by: Duaran Lopes de Sousa, et al.
Published: (2025-08-01)
by: Duaran Lopes de Sousa, et al.
Published: (2025-08-01)
The Role of KEAP1-NRF2 System in Atopic Dermatitis and Psoriasis
by: Tatsuya Ogawa, et al.
Published: (2022-07-01)
by: Tatsuya Ogawa, et al.
Published: (2022-07-01)
Mechanisms of Keap1/Nrf2 modulation in bacterial infections: implications in persistence and clearance
by: Marco Antonio Romero-Durán, et al.
Published: (2024-12-01)
by: Marco Antonio Romero-Durán, et al.
Published: (2024-12-01)
Transcriptomic Characterization Reveals Mitochondrial Involvement in Nrf2/Keap1-Mediated Osteoclastogenesis
by: Eiko Sakai, et al.
Published: (2024-12-01)
by: Eiko Sakai, et al.
Published: (2024-12-01)
Research progress on the role of Nrf2-Keap1 signaling pathway in acute kidney injury
by: HUANG Xi-jie, et al.
Published: (2019-01-01)
by: HUANG Xi-jie, et al.
Published: (2019-01-01)
Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features
by: Yu XIAO, et al.
Published: (2018-03-01)
by: Yu XIAO, et al.
Published: (2018-03-01)
NRF2 pathway activation by KEAP1 inhibition attenuates the manifestation of aging phenotypes in salivary glands
by: Sisca Meida Wati, et al.
Published: (2020-09-01)
by: Sisca Meida Wati, et al.
Published: (2020-09-01)
KLF5 promotes esophageal squamous cell carcinoma radioresistance by targeting the Keap1-Nrf2 pathway
by: Yang Wang, et al.
Published: (2025-02-01)
by: Yang Wang, et al.
Published: (2025-02-01)
Modulation of Keap1/Nrf2/ARE Signaling Pathway by Curcuma- and Garlic-Derived Hybrids
by: Melania Maria Serafini, et al.
Published: (2020-01-01)
by: Melania Maria Serafini, et al.
Published: (2020-01-01)
Cancer Chemopreventive Role of Dietary Terpenoids by Modulating Keap1-Nrf2-ARE Signaling System—A Comprehensive Update
by: Md Afjalus Siraj, et al.
Published: (2021-11-01)
by: Md Afjalus Siraj, et al.
Published: (2021-11-01)
A Bibliometric Review of the Keap1/Nrf2 Pathway and its Related Antioxidant Compounds
by: Ana Paunkov, et al.
Published: (2019-09-01)
by: Ana Paunkov, et al.
Published: (2019-09-01)
Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease
by: Waseem Chauhan, et al.
Published: (2023-03-01)
by: Waseem Chauhan, et al.
Published: (2023-03-01)
MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
by: Xing Luo, et al.
Published: (2024-02-01)
by: Xing Luo, et al.
Published: (2024-02-01)
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
by: Emiliano Panieri, et al.
Published: (2020-05-01)
by: Emiliano Panieri, et al.
Published: (2020-05-01)
Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress
by: Shunhao Zhang, et al.
Published: (2022-06-01)
by: Shunhao Zhang, et al.
Published: (2022-06-01)
The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones
by: Matheus de Freitas Silva, et al.
Published: (2018-07-01)
by: Matheus de Freitas Silva, et al.
Published: (2018-07-01)
Oxycodone alleviates mifepristone‐stimulated human endometrial stromal cell injury by activating the Keap1/Nrf2/HO‐1 signaling pathway
by: Aibing Zhu, et al.
Published: (2023-09-01)
by: Aibing Zhu, et al.
Published: (2023-09-01)
Repurposing of epalrestat for neuroprotection in parkinson’s disease via activation of the KEAP1/Nrf2 pathway
by: Huafang Jia, et al.
Published: (2025-04-01)
by: Huafang Jia, et al.
Published: (2025-04-01)
Similar Items
-
Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA
by: Eva Schrom, et al.
Published: (2017-06-01) -
KEAP1/NRF2 as a druggable target
by: Dinkova-Kostova Albena T.
Published: (2023-01-01) -
CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis
by: Yanbo Wang, et al.
Published: (2021-05-01) -
The KEAP1-NRF2 pathway: Targets for therapy and role in cancer
by: Simone Adinolfi, et al.
Published: (2023-07-01) -
Potential Benefits of Nrf2/Keap1 Targeting in Pancreatic Islet Cell Transplantation
by: Alberto Jarrin Lopez, et al.
Published: (2020-04-01)
